Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis

计划入组 153 人 · 首次发布于 2016 年 4 月 21 日

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert

计划入组 129 人 · 首次发布于 2012 年 9 月 27 日

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal (FAI) Insert

计划入组 12 人 · 首次发布于 2021 年 10 月 7 日

TNF-alpha inhibitors (AAV8, non-infectious uveitis)

Fluocinolone acetonide(Capex, Derma-Smoothe/FS, Derma-smoothe FS, Dermotic, Flac, Iluvien, Neo-synalar, Otixal, Otovel, Retisert, Synalar, Tri-luma, Yutiq)

C₂₄H₃₀F₂O₆

scAAV9.U7.ACCA

The Cooper Health System, A New Jersey Non-Profit Corporation

United States

Kineta Chronic Pain LLC

United States

Uniformed Services University Of The Health Sciences

United States

FDA Approves ILUVIEN Label Expansion for Chronic Non-Infectious Uveitis Treatment

ILUVIEN Meets Both Co-Primary Endpoints in Phase 4 SYNCHRONICITY Trial for Chronic Non-Infectious Uveitis

Uveitis and Optic Neuritis Markets Set for Major Growth Through 2034 as New Therapies Advance